Cargando…
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario
Urothelial carcinoma (UC) is the most frequent malignancy of the urinary tract, which consists of bladder cancer (BC) for 90%, while 5% to 10%, of urinary tract UC (UTUC). BC and UTUC are characterized by distinct phenotypical and genotypical features as well as specific gene- and protein- expressio...
Autores principales: | Mazzaschi, Giulia, Giudice, Giulia Claire, Corianò, Matilde, Campobasso, Davide, Perrone, Fabiana, Maffezzoli, Michele, Testi, Irene, Isella, Luca, Maestroni, Umberto, Buti, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983117/ https://www.ncbi.nlm.nih.gov/pubmed/36855829 http://dx.doi.org/10.1177/15330338231159753 |
Ejemplares similares
-
Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review
por: Mazzaschi, Giulia, et al.
Publicado: (2022) -
Pazopanib as a possible option for the treatment of metastatic
non-clear cell renal carcinoma patients: a systematic review
por: Bersanelli, Melissa, et al.
Publicado: (2020) -
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study
por: Buti, Sebastiano, et al.
Publicado: (2021) -
Metastatic Clear Cell Renal Cell Carcinoma: The Great Pretender and the Great Dilemma
por: Maestroni, Umberto, et al.
Publicado: (2021) -
PSA-IgM and iXip in the diagnosis and management of prostate cancer: clinical relevance and future potential. A review.
por: Maestroni, Umberto, et al.
Publicado: (2021)